Eridanus WhatsApp
Palce A Enqirey
Banner background

Sodium Valproate & Valproic Acid 200 mg

Product Image
Product 1
Product 2
Eridanus Healthcare
Tablet Range

VENIT-CR-200

Composition :

Sodium Valproate & Valproic Acid 200 mg

Packaging Type:

Box

Dimensions:

10*10 ALU ALU

Min Order Qty:

1

G. S. T (%)

0 %

VENIT-CR-200 contains Sodium Valproate & Valproic Acid 200 mg, a commonly prescribed neurological medicine used for the treatment and management of epilepsy, seizure disorders, bipolar disorder, and migraine prevention. It helps patients control recurrent seizures and supports better neurological functioning. Due to its effectiveness in long-term therapy, this formulation is frequently recommended by healthcare professionals for patients suffering from various neurological conditions.

The active ingredients in VENIT-CR-200 work by increasing the concentration of gamma-aminobutyric acid (GABA), a neurotransmitter responsible for reducing excessive nerve activity in the brain. By stabilising abnormal electrical signals, the medicine helps prevent seizures and improve neurological stability. The controlled-release formulation provides sustained medication release, ensuring prolonged therapeutic benefits and improved patient compliance.

Sodium Valproate & Valproic Acid Tablets PCD Pharma Franchise, Manufacturer, Supplier - Eridanus Healthcare

Eridanus Healthcare is a trusted name in the pharmaceutical industry, offering a lucrative Sodium Valproate & Valproic Acid tablets PCD Pharma Franchise opportunity for pharma distributors, business executives, and entrepreneurs across India. As a reputed Sodium Valproate & Valproic Acid tablets manufacturer & supplier, the company ensures superior product quality, attractive packaging, timely product availability, and competitive pricing. Franchise partners receive extensive business support, including promotional tools, marketing assistance, and monopoly-based rights in selected regions. Backed by a strong neuropsychiatric product portfolio and a commitment to quality, Eridanus Healthcare helps its associates establish a profitable and sustainable pharmaceutical business in a competitive market.

Key Benefits of Sodium Valproate + Valproic Acid Tablets

  • Helps manage different types of epilepsy and seizure disorders.
  • Assists in preventing migraine attacks.
  • Supports the treatment of bipolar disorder and mood stabilisation.
  • Provides controlled and sustained drug release for better effectiveness.
  • Enhances patient compliance with long-term treatment plans.
  • Widely prescribed by neurologists and healthcare professionals.

Potential Side Effects and Precautions

Like other neurological medicines, Sodium Valproate & Valproic Acid 200 mg may cause certain side effects in some patients. Commonly reported effects include nausea, dizziness, drowsiness, stomach discomfort, tremors, weight gain, and mild fatigue. These side effects are generally manageable and may reduce over time.

Patients should use this medicine strictly under medical supervision and follow the prescribed dosage instructions. Regular monitoring by healthcare professionals is recommended, especially during long-term treatment, to ensure optimal therapeutic outcomes.

Grow Your Pharma Business with Eridanus Healthcare

The Sodium Valproate & Valproic Acid 200 mg PCD Pharma Franchise offered by Eridanus Healthcare is an excellent opportunity for pharma professionals looking to expand their business in the neurological healthcare segment. With its reputation as a trusted Sodium Valproate & Valproic Acid 200 mg manufacturer and Sodium Valproate & Valproic Acid 200 mg supplier, the company provides the products, support, and business advantages required for long-term success in the pharmaceutical industry.